Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)
:2185
Want to see HK:2185 full AI Analyst Report?
Total Valuation
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has a market cap or net worth of HK$851.96M. The enterprise value is HK$636.31M.
Market CapHK$851.96M
Enterprise ValueHK$636.31M
Share Statistics
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has 235,703,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding235,703,410
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -6.15%.
Return on Equity (ROE)-0.16
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-6.15%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee694.75K
Profits Per Employee-1.08M
Employee Count63
Asset Turnover0.05
Inventory Turnover1.18
Valuation Ratios
The current PE Ratio of Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is ―. Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s PEG ratio is 0.83.
PE Ratio―
PS Ratio28.92
PB Ratio2.91
Price to Fair Value2.91
Price to FCF-17.36
Price to Operating Cash Flow-12.36
PEG Ratio0.83
Income Statement
In the last 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H had revenue of 43.77M and earned -68.24M in profits. Earnings per share was -0.28.
Revenue43.77M
Gross Profit-157.81K
Operating Income-69.84M
Pretax Income-93.52M
Net Income-68.24M
EBITDA-52.13M
Earnings Per Share (EPS)-0.28
Cash Flow
In the last 12 months, operating cash flow was -57.93M and capital expenditures -7.27M, giving a free cash flow of -65.20M billion.
Operating Cash Flow-57.93M
Free Cash Flow-65.20M
Free Cash Flow per Share-0.28
Dividends & Yields
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.65
52-Week Price Change36.72%
50-Day Moving Average4.28
200-Day Moving Average5.96
Relative Strength Index (RSI)32.71
Average Volume (3m)2.14M
Important Dates
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H upcoming earnings date is Jul 31, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateJul 31, 2026
Ex-Dividend Date―
Financial Position
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H as a current ratio of 15.26, with Debt / Equity ratio of 2.93%
Current Ratio15.26
Quick Ratio13.77
Debt to Market Cap<0.01
Net Debt to EBITDA1.53
Interest Coverage Ratio-8.20
Taxes
In the past 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has paid -26.86M in taxes.
Income Tax-26.86M
Effective Tax Rate0.29
Enterprise Valuation
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H EV to EBITDA ratio is -22.76, with an EV/FCF ratio of -16.27.
EV to Sales27.10
EV to EBITDA-22.76
EV to Free Cash Flow-16.27
EV to Operating Cash Flow-18.12
Balance Sheet
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has HK$248.63M in cash and marketable securities with HK$12.73M in debt, giving a net cash position of HK$235.90M billion.
Cash & Marketable SecuritiesHK$248.63M
Total DebtHK$12.73M
Net CashHK$235.90M
Net Cash Per ShareHK$1.00
Tangible Book Value Per ShareHK$1.40
Margins
Gross margin is 17.17%, with operating margin of -159.56%, and net profit margin of -155.91%.
Gross Margin17.17%
Operating Margin-159.56%
Pretax Margin-213.66%
Net Profit Margin-155.91%
EBITDA Margin-119.10%
EBIT Margin-159.56%
Analyst Forecast
The average price target for Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast20.16%